Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans.

Arginine:glycine amidinotransferase (AGAT) catalyzes the first step of creatine synthesis, resulting in the formation of guanidinoacetate, which is a substrate for creatine formation. In two female siblings with mental retardation who had brain creatine deficiency that was reversible by means of oral creatine supplementation and had low urinary guanidinoacetate concentrations, AGAT deficiency was identified as a new genetic defect in creatine metabolism. A homozygous G-A transition at nucleotide position 9297, converting a tryptophan codon (TGG) to a stop codon (TAG) at residue 149 (T149X), resulted in undetectable cDNA, as investigated by reverse-transcription PCR, as well as in undetectable AGAT activity, as investigated radiochemically in cultivated skin fibroblasts and in virus-transformed lymphoblasts of the patients. The parents were heterozygous for the mutant allele, with intermediate residual AGAT activities. Recognition and treatment with oral creatine supplements may prevent neurological sequelae in affected patients.

[1]  J. Walker.  Creatine: biosynthesis, regulation, and function. , 2006, Advances in enzymology and related areas of molecular biology.

[2]  William S. Ball,et al.  X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. , 2001, American journal of human genetics.

[3]  W. O'Brien,et al.  Analysis of guanidinoacetate and creatine by isotope dilution electrospray tandem mass spectrometry. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[4]  B. Wong,et al.  Irreversible brain creatine deficiency with elevated serum and urine creatine: A creatine transporter defect? , 2001, Annals of neurology.

[5]  R. Cotton.  Methods in clinical molecular genetics , 2000, European Journal of Pediatrics.

[6]  M. Tosetti,et al.  Brain creatine depletion: Guanidinoacetate methyltransferase deficiency (improving with creatine supplementation) , 2000, Neurology.

[7]  M. Tosetti,et al.  Reversible brain creatine deficiency in two sisters with normal blood creatine level , 2000, Annals of neurology.

[8]  P. Pouwels,et al.  Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect , 2000, Annals of neurology.

[9]  S. Stöckler‐Ipsiroglu,et al.  Guanidinoacetate methyltransferase (GAMT) deficiency: non-invasive enzymatic diagnosis of a newly recognized inborn error of metabolism. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[10]  M. Upadhyaya,et al.  Evaluation of the protein truncation test and mutation detection in the NF1 gene: mutational analysis of 15 known and 40 unknown mutations , 1999, Human Genetics.

[11]  H. J. Brink,et al.  An accurate stable isotope dilution gas chromatographic-mass spectrometric approach to the diagnosis of guanidinoacetate methyltransferase deficiency. , 1998, Journal of pharmaceutical and biomedical analysis.

[12]  S. Stöckler‐Ipsiroglu.  Creatine deficiency syndromes: a new perspective on metabolic disorders and a diagnostic challenge. , 1997, The Journal of pediatrics.

[13]  P. D. De Deyn,et al.  Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis. , 1997, Metabolism: clinical and experimental.

[14]  M. Knopp,et al.  Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism. , 1997, The Journal of pediatrics.

[15]  A. Connelly,et al.  Guanidinoacetate methyltransferase deficiency: new clinical features. , 1997, Pediatric neurology.

[16]  R. Huber,et al.  Recombinant expression and isolation of human L-arginine:glycine amidinotransferase and identification of its active-site cysteine residue. , 1997, The Biochemical journal.

[17]  Jens Frahm,et al.  Creatine replacement therapy in guanidineoacetate methyltransferase deficiency, a novel inborn error of metabolism , 1996, The Lancet.

[18]  F. Hanefeld,et al.  Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. , 1996, American journal of human genetics.

[19]  I. Sora,et al.  The cloning and expression of a human creatine transporter. , 1994, Biochemical and biophysical research communications.

[20]  G Helms,et al.  Creatine Deficiency in the Brain: A New, Treatable Inborn Error of Metabolism , 1994, Pediatric Research.

[21]  P. Guldberg,et al.  A simple method for identification of point mutations using denaturing gradient gel electrophoresis. , 1993, Nucleic acids research.

[22]  M. Kilimann,et al.  A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression. , 1993, The Journal of biological chemistry.

[23]  C R Scriver,et al.  Proof of “disease causing” mutation , 1998, Human mutation.

[24]  P. Guldberg,et al.  Molecular heterogeneity of classical and duarte galactosemia: Mutation analysis by denaturing gradient gel electrophoresis , 1997, Human mutation.

[25]  G. C. Stephens,et al.  Distribution of creatine, guanidinoacetate and the enzymes for their biosynthesis in the animal kingdom. Implications for phylogeny. , 1972, The Biochemical journal.